Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature

Neuroscience and Biobehavioral Reviews

Volumn 71, Issue , 2016, Pages 176-197

  Raab, Kyeon ^a,b   Kirsch, Peter ^a   Mier, Daniela ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 HTTLPR; Acute tryptophan depletion; Amygdala; Anterior cingulate cortex; Candidate gene; Corticolimbic; Emotion; Emotion recognition; Face processing; Imaging genetics; Medial prefrontal cortex; Orbitofrontal cortex; Serotonin; Serotonin receptor; Serotonin transporter; Social cognition; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN;

BRAIN FUNCTION; EMOTIONALITY; EXECUTIVE FUNCTION; FACIAL EXPRESSION; FUNCTIONAL NEUROIMAGING; GENE STRUCTURE; GENETIC RISK; HUMAN; MOLECULAR IMAGING; NERVE CELL NETWORK; NEUROANATOMY; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PHENOTYPE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEROTONIN TRANSPORTER GENE LINKED POLYMORPHIC REGION; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; BRAIN; EMOTION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTIDEPRESSIVE AGENTS; BRAIN; EMOTIONS; FACIAL EXPRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN;

EID: 84986209158     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.08.031     Document Type: Review

References (286)

1. Abi-Saab, W.M., Bubser, M., Roth, R.H., Deutch, A.Y., 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 20 (1999), 92–96, 10.1016/S0893-133X(98)00046-3.
2. Adell, A., Artigas, F., Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 343 (1991), 237–244.
3. Adolphs, R., Tranel, D., Damasio, H., Damasio, A.R., Fear and the human amygdala. J. Neurosci. 15 (1995), 5879–5891.
4. Adolphs, R., Tranel, D., Hamann, S., Young, A.W., Calder, A.J., Phelps, E.A., Anderson, A., Lee, G.P., Damasio, A.R., Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia 37 (1999), 1111–1117.
5. Adolphs, R., The neurobiology of social cognition. Curr. Opin. Neurobiol. 11 (2001), 231–239.
6. Adolphs, R., Recognizing emotion from facial expressions: psychological and neurological mechanisms. Behav. Cogn. Neurosci. Rev. 1 (2002), 21–62.
7. Adolphs, R., Neural systems for recognizing emotion. Curr. Opin. Neurobiol. 12 (2002), 169–177.
8. Adolphs, R., Cognitive neuroscience of human social behaviour. Nat. Rev. Neurosci. 4 (2003), 165–178, 10.1038/nrn1056.
9. Aghajanian, G.K., Marek, G.J., Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825 (1999), 161–171.
10. Akimova, E., Lanzenberger, R., Kasper, S., The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry 66 (2009), 627–635, 10.1016/j.biopsych.2009.03.012.
11. Aloyo, V.J., Berg, K.A., Clarke, W.P., Spampinato, U., Harvey, J.A., Inverse agonism at serotonin and cannabinoid receptors. Prog. Mol. Biol. Transl. Sci. 91 (2010), 1–40, 10.1016/S1877-1173(10)91001-6.
12. Altieri, S.C., Garcia-Garcia, A.L., Leonardo, E.D., Andrews, A.M., Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem. Neurosci. 4 (2013), 72–83, 10.1021/cn3002174.
13. Amaral, D.G., Price, J.L., Amygdalo-cortical projections in the monkey (Macaca fascicularis). J. Comp. Neurol. 230 (1984), 465–496, 10.1002/cne.902300402.
14. Amargós-Bosch, M., Bortolozzi, A., Puig, M.V., Serrats, J., Adell, A., Celada, P., Toth, M., Mengod, G., Artigas, F., Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 14 (2004), 281–299.
15. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Arlington.
16. Anderson, I.M., Del-Ben, C.M., Mckie, S., Richardson, P., Williams, S.R., Elliott, R., Deakin, J.F.W., Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport 18 (2007), 1351–1355, 10.1097/WNR.0b013e3282742115.
17. Andrade, R., Haj-Dahmane, S., Serotonin neuron diversity in the dorsal raphe. ACS Chem. Neurosci. 4 (2013), 22–25, 10.1021/cn300224n.
18. Ansorge, M.S., Zhou, M., Lira, A., Hen, R., Gingrich, J.A., Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004), 879–881, 10.1126/science.1101678.
19. Arce, E., Simmons, A.N., Lovero, K.L., Stein, M.B., Paulus, M.P., Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl.) 196 (2008), 661–672, 10.1007/s00213-007-1004-8.
20. Artigas, F., Romero, L., de Montigny, C., Blier, P., Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19 (1996), 378–383, 10.1016/S0166-2236(96)10037-0.
21. Artigas, F., Serotonin receptors involved in antidepressant effects. Pharmacol. Ther. 137 (2013), 119–131, 10.1016/j.pharmthera.2012.09.006.
22. Aznar, S., Klein, A.B., Regulating prefrontal cortex activation: an emerging role for the 5-HT2A serotonin receptor in the modulation of emotion-based actions?. Mol. Neurobiol. 48 (2013), 841–853, 10.1007/s12035-013-8472-0.
23. Balcioglu, A., Wurtman, R.J., Striatal serotonin receptors and dopamine release. J. Neurochem., 75, 2000, 886.
24. Barbas, H., De Olmos, J., Projections from the amygdala to basoventral and mediodorsal prefrontal regions in the rhesus monkey. J. Comp. Neurol. 300 (1990), 549–571, 10.1002/cne.903000409.
25. Barnes, N.M., Sharp, T., A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999), 1083–1152.
26. Barnes, J.J.M., Dean, A.J., Nandam, L.S., O'Connell, R.G., Bellgrove, M.A., The molecular genetics of executive function: role of monoamine system genes. Biol. Psychiatry 69 (2011), e127–143, 10.1016/j.biopsych.2010.12.040.
27. Bastiaansen, J.A., Servaas, M.N., Marsman, J.B.C., Ormel, J., Nolte, I.M., Riese, H., Aleman, A., Filling the gap: relationship between the serotonin-transporter-linked polymorphic region and amygdala activation. Psychol. Sci. 25 (2014), 2058–2066, 10.1177/0956797614548877.
28. Battaglia, M., Zanoni, A., Taddei, M., Giorda, R., Bertoletti, E., Lampis, V., Scaini, S., Cappa, S., Tettamanti, M., Cerebral responses to emotional expressions and the development of social anxiety disorder: a preliminary longitudinal study. Depression Anxiety 29 (2012), 54–61, 10.1002/da.20896.
29. Bel, N., Artigas, F., Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229 (1992), 101–103.
30. Bel, N., Artigas, F., Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15 (1993), 243–245, 10.1002/syn.890150310.
31. Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., Williams, R., Vulnerability genes or plasticity genes?. Mol. Psychiatry 14 (2009), 746–754, 10.1038/mp.2009.44.
32. Bertolino, A., Arciero, G., Rubino, V., Latorre, V., De Candia, M., Mazzola, V., Blasi, G., Caforio, G., Hariri, A., Kolachana, B., Nardini, M., Weinberger, D.R., Scarabino, T., Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style. Biol. Psychiatry 57 (2005), 1517–1525, 10.1016/j.biopsych.2005.02.031.
33. Bethlehem, R.A.I., van Honk, J., Auyeung, B., Baron-Cohen, S., Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 38 (2013), 962–974, 10.1016/j.psyneuen.2012.10.011.
34. Bevilacqua, L., Goldman, D., Genetics of emotion. Trends Cogn. Sci. 15 (2011), 401–408, 10.1016/j.tics.2011.07.009.
35. Bigos, K.L., Hariri, A.R., Neuroimaging: technologies at the interface of genes, brain, and behavior. Neuroimaging Clin. N. Am. 17 (2007), 459–467, 10.1016/j.nic.2007.09.005.
36. Bigos, K.L., Weinberger, D.R., Imaging genetics—days of future past. NeuroImage 53 (2010), 804–809, 10.1016/j.neuroimage.2010.01.035.
37. Bigos, K.L., Pollock, B.G., Aizenstein, H.J., Fisher, P.M., Bies, R.R., Hariri, A.R., Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 33 (2008), 3221–3225, 10.1038/npp.2008.52.
38. Birnbaum, R., Weinberger, D.R., Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk. Dialogues Clin. Neurosci. 15 (2013), 279–289.
39. Blier, P., de Montigny, C., Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994), 220–226.
40. Blier, P., de Montigny, C., Chaput, Y., A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J. Clin. Psychiatry 51:Suppl (1990), 14–20 (discussion 21).
41. Blokland, A., Lieben, C., Deutz, N.E.P., Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J. Psychopharmacol. Oxf. Engl. 16 (2002), 39–49.
42. Bourke, C., Douglas, K., Porter, R., Processing of facial emotion expression in major depression: a review. Aust. N. Z. J. Psychiatry 44 (2010), 681–696, 10.3109/00048674.2010.496359.
43. Bragado-Jimenez, M.D., Taylor, P.J., Empathy, schizophrenia and violence: a systematic review. Schizophr. Res. 141 (2012), 83–90, 10.1016/j.schres.2012.07.019.
44. Brothers, L., Ring, B., A neuroethological framework for the representation of minds. J. Cogn. Neurosci. 4 (1992), 107–118.
45. Brothers, L., The social brain: a project for integrating primate behavior and neurophysiology in a new domain. Concepts Neurosci. 1 (1990), 27–51.
46. Buckholtz, J.W., Meyer-Lindenberg, A., MAOA and the neurogenetic architecture of human aggression. Trends Neurosci. 31 (2008), 120–129, 10.1016/j.tins.2007.12.006.
47. Cahir, M., Ardis, T., Reynolds, G.P., Cooper, S.J., Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl.) 190 (2007), 497–506, 10.1007/s00213-006-0635-5.
48. Calder, A.J., Lawrence, A.D., Young, A.W., Neuropsychology of fear and loathing. Nat. Rev. Neurosci. 2 (2001), 352–363, 10.1038/35072584.
49. Campbell, B.M., Merchant, K.M., Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res. 993 (2003), 1–9.
50. Canli, T., Lesch, K.P., Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 10 (2007), 1103–1109, 10.1038/nn1964.
51. Canli, T., Qiu, M., Omura, K., Congdon, E., Haas, B.W., Amin, Z., Herrmann, M.J., Constable, R.T., Lesch, K.P., Neural correlates of epigenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 16033–16038, 10.1073/pnas.0601674103.
52. Canli, T., Congdon, E., Todd Constable, R., Lesch, K.P., Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol. Psychol. 79 (2008), 118–125, 10.1016/j.biopsycho.2008.01.004.
53. Cansev, M., Wurtman, R.J., Aromatic amino acids in the brain. Lajtha, A., (eds.) Amino Acids and Peptides in the Nervous System, Handbook of Neurochemistry and Molecular Neurobiology, vol. 6, 2007, Springer-Verlag, Berlin Heidelberg, 59–97.
54. Carmichael, S.T., Price, J.L., Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J. Comp. Neurol. 363 (1995), 615–641, 10.1002/cne.903630408.
55. Carpenter, L.L., Anderson, G.M., Pelton, G.H., Gudin, J.A., Kirwin, P.D., Price, L.H., Heninger, G.R., McDougle, C.J., Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 19 (1998), 26–35, 10.1016/S0893-133X(97)00198-X.
56. Carter, C.S., Braver, T.S., Barch, D.M., Botvinick, M.M., Noll, D., Cohen, J.D., Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280 (1998), 747–749.
57. Casanovas, J.M., Vilaró, M.T., Mengod, G., Artigas, F., Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. J. Neurochem. 72 (1999), 262–272.
58. Casey, B.J., Oliveri, M.E., Insel, T., A neurodevelopmental perspective on the research domain criteria (RDoC) framework. Biol. Psychiatry 76 (2014), 350–353, 10.1016/j.biopsych.2014.01.006.
59. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., Poulton, R., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–389, 10.1126/science.1083968.
60. Celada, P., Puig, M.V., Casanovas, J.M., Guillazo, G., Artigas, F., Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 (2001), 9917–9929.
61. Celada, P., Puig, M., Amargós-Bosch, M., Adell, A., Artigas, F., The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J. Psychiatry Neurosci. 29 (2004), 252–265.
62. Chang, A.S., Chang, S.M., Starnes, D.M., Schroeter, S., Bauman, A.L., Blakely, R.D., Cloning and expression of the mouse serotonin transporter. Brain Res. Mol. Brain Res. 43 (1996), 185–192.
63. Chen, A., Hough, C.J., Li, H., Serotonin type II receptor activation facilitates synaptic plasticity via N-methyl-D-aspartate-mediated mechanism in the rat basolateral amygdala. Neuroscience 119 (2003), 53–63.
64. Cloninger, C.R., The discovery of susceptibility genes for mental disorders. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 13365–13367, 10.1073/pnas.222532599.
65. Cools, R., Calder, A.J., Lawrence, A.D., Clark, L., Bullmore, E., Robbins, T.W., Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology (Berl.) 180 (2005), 670–679, 10.1007/s00213-005-2215-5.
66. Cools, R., Roberts, A.C., Robbins, T.W., Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 12 (2008), 31–40, 10.1016/j.tics.2007.10.011.
67. Coplan, J.D., Gopinath, S., Abdallah, C.G., Berry, B.R., A neurobiological hypothesis of treatment-resistant depression—mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front. Behav. Neurosci., 8, 2014, 189, 10.3389/fnbeh.2014.00189.
68. Costafreda, S.G., McCann, P., Saker, P., Cole, J.H., Cohen-Woods, S., Farmer, A.E., Aitchison, K.J., McGuffin, P., Fu, C.H.Y., Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. J. Affect. Disord. 150 (2013), 96–103, 10.1016/j.jad.2013.02.028.
69. Cowan, W.M., Kopnisky, K.L., Hyman, S.E., The human genome project and its impact on psychiatry. Annu. Rev. Neurosci. 25 (2002), 1–50, 10.1146/annurev.neuro.25.112701.142853.
70. Craddock, N., Sklar, P., Genetics of bipolar disorder. Lancet 381 (2013), 1654–1662, 10.1016/S0140-6736(13)60855-7.
71. Crockett, M.J., Clark, L., Roiser, J.P., Robinson, O.J., Cools, R., Chase, H.W., Ouden, H., den Apergis-Schoute, A., Campbell-Meiklejohn, D., Campbell-Meikeljohn, D., Seymour, B., Sahakian, B.J., Rogers, R.D., Robbins, T.W., Converging evidence for central 5-HT effects in acute tryptophan depletion. Mol. Psychiatry 17 (2012), 121–123, 10.1038/mp.2011.106.
72. Cusi, A.M., Nazarov, A., Holshausen, K., Macqueen, G.M., McKinnon, M.C., Systematic review of the neural basis of social cognition in patients with mood disorders. J. Psychiatry Neurosci. 37 (2012), 154–169, 10.1503/jpn.100179.
73. Cuthbert, B.N., Insel, T.R., Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med., 11, 2013, 126, 10.1186/1741-7015-11-126.
74. Cuthbert, B.N., Kozak, M.J., Constructing constructs for psychopathology: the NIMH research domain criteria. J. Abnorm. Psychol. 122 (2013), 928–937, 10.1037/a0034028.
75. Cuthbert, B.N., The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13 (2014), 28–35, 10.1002/wps.20087.
76. Cuthbert, B.N., Research domain criteria: toward future psychiatric nosologies. Dialogues Clin. Neurosci. 17 (2015), 89–97.
77. Dannlowski, U., Ohrmann, P., Bauer, J., Deckert, J., Hohoff, C., Kugel, H., Arolt, V., Heindel, W., Kersting, A., Baune, B.T., Suslow, T., 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 33 (2008), 418–424, 10.1038/sj.npp.1301411.
78. Dannlowski, U., Konrad, C., Kugel, H., Zwitserlood, P., Domschke, K., Schöning, S., Ohrmann, P., Bauer, J., Pyka, M., Hohoff, C., Zhang, W., Baune, B.T., Heindel, W., Arolt, V., Suslow, T., Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. NeuroImage 53 (2010), 893–898, 10.1016/j.neuroimage.2009.11.073.
79. Darwin, C., The Expression of the Emotions in Man and Animals. 1965, Univ. of Chicago Press, Chicago (Original work published 1872).
80. David, S.P., Murthy, N.V., Rabiner, E.A., Munafó, M.R., Johnstone, E.C., Jacob, R., Walton, R.T., Grasby, P.M., A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25 (2005), 2586–2590, 10.1523/JNEUROSCI.3769-04.2005.
81. De Almeida, J., Mengod, G., Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J. Neurochem. 103 (2007), 475–486, 10.1111/j.1471-4159.2007.04768.x.
82. De Mello Cruz, A.P., Pinheiro, G., Alves, S.H., Ferreira, G., Mendes, M., Faria, L., Macedo, C.E., Motta, V., Landeira-Fernandez, J., Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology (Berl.) 182 (2005), 345–354, 10.1007/s00213-005-0108-2.
83. Decety, J., Jackson, P.L., The functional architecture of human empathy. Behav. Cogn. Neurosci. Rev. 3 (2004), 71–100, 10.1177/1534582304267187.
84. Del-Ben, C.M., Deakin, J.F.W., McKie, S., Delvai, N.A., Williams, S.R., Elliott, R., Dolan, M., Anderson, I.M., The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30 (2005), 1724–1734, 10.1038/sj.npp.1300728.
85. Del-Ben, C.M., Ferreira, C.A.Q., Alves-Neto, W.C., Graeff, F.G., Serotonergic modulation of face-emotion recognition. Braz. J. Med. Biol. Res. 41 (2008), 263–269.
86. Demenescu, L.R., Kortekaas, R., den Boer, J.A., Aleman, A., Impaired attribution of emotion to facial expressions in anxiety and major depression. PLoS One, 5, 2010, e15058, 10.1371/journal.pone.0015058.
87. Di Simplicio, M., Norbury, R., Reinecke, A., Harmer, C.J., Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism. Psychol. Med. 44 (2014), 241–252, 10.1017/S0033291713000731.
88. Domingos da Silveira da Luz, A.C., Pereira Dias, G., do Nascimento Bevilaqua, M.C., Cocks, G., Gardino, P.F., Thuret, S., Nardi, A.E., Translational findings on brain-derived neurotrophic factor and anxiety: contributions from basic research to clinical practice. Neuropsychobiology 68 (2013), 129–138, 10.1159/000353269.
89. Domschke, K., Dannlowski, U., Imaging genetics of anxiety disorders. NeuroImage 53 (2010), 822–831, 10.1016/j.neuroimage.2009.11.042.
90. Domschke, K., Baune, B.T., Havlik, L., Stuhrmann, A., Suslow, T., Kugel, H., Zwanzger, P., Grotegerd, D., Sehlmeyer, C., Arolt, V., Dannlowski, U., Catechol-O-methyltransferase gene variation: impact on amygdala response to aversive stimuli. NeuroImage 60 (2012), 2222–2229, 10.1016/j.neuroimage.2012.02.039.
91. Drago, A., Serretti, A., Focus on HTR2C: a possible suggestion for genetic studies of complex disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009), 601–637, 10.1002/ajmg.b.30864.
92. Ebdrup, B.H., Rasmussen, H., Arnt, J., Glenthøj, B., Serotonin 2A receptor antagonists for treatment of schizophrenia. Expert Opin. Investig. Drugs 20 (2011), 1211–1223, 10.1517/13543784.2011.601738.
93. Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D., Weinberger, D.R., Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 6917–6922, 10.1073/pnas.111134598.
94. Ekman, P., An argument for basic emotions. Cogn. Emot. 6 (1992), 169–200.
95. El Mansari, M., Sánchez, C., Chouvet, G., Renaud, B., Haddjeri, N., Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30 (2005), 1269–1277, 10.1038/sj.npp.1300686.
96. Evers, E.A.T., Sambeth, A., Ramaekers, J.G., Riedel, W.J., van der Veen, F.M., The effects of acute tryptophan depletion on brain activation during cognition and emotional processing in healthy volunteers. Curr. Pharm. Des. 16 (2010), 1998–2011.
97. Fisher, P.M., Hariri, A.R., Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 368, 2013, 20120192, 10.1098/rstb.2012.0192.
98. Fisher, P.M., Meltzer, C.C., Ziolko, S.K., Price, J.C., Moses-Kolko, E.L., Berga, S.L., Hariri, A.R., Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat. Neurosci. 9 (2006), 1362–1363, 10.1038/nn1780.
99. Fisher, P.M., Meltzer, C.C., Price, J.C., Coleman, R.L., Ziolko, S.K., Becker, C., Moses-Kolko, E.L., Berga, S.L., Hariri, A.R., Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb. Cortex 19 (2009), 2499–2507, 10.1093/cercor/bhp022.
100. Fisher, P.M., Price, J.C., Meltzer, C.C., Moses-Kolko, E.L., Becker, C., Berga, S.L., Hariri, A.R., Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity. Biol. Mood Anxiety Disord., 1, 2011, 2, 10.1186/2045-5380-1-2.
101. Fisher, P.M., Madsen, M.K., Mc Mahon, B., Holst, K.K., Andersen, S.B., Laursen, H.R., Hasholt, L.F., Siebner, H.R., Knudsen, G.M., Three-week bright-light intervention has dose-related effects on threat-related corticolimbic reactivity and functional coupling. Biol. Psychiatry 76 (2014), 332–339, 10.1016/j.biopsych.2013.11.031.
102. Fisher, P.M., Grady, C.L., Madsen, M.K., Strother, S.C., Knudsen, G.M., 5-HTTLPR differentially predicts brain network responses to emotional faces. Hum. Brain Mapp. 36 (2015), 2842–2851, 10.1002/hbm.22811.
103. Flint, J., Kendler, K.S., The genetics of major depression. Neuron 81 (2014), 484–503, 10.1016/j.neuron.2014.01.027.
104. Flint, J., Munafò, M.R., The endophenotype concept in psychiatric genetics. Psychol. Med. 37 (2007), 163–180, 10.1017/S0033291706008750.
105. Frith, C.D., Corcoran, R., Exploring theory of mind in people with schizophrenia. Psychol. Med. 26 (1996), 521–530.
106. Frith, C.D., Frith, U., Interacting minds—a biological basis. Science 286 (1999), 1692–1695.
107. Frith, U., Frith, C.D., Development and neurophysiology of mentalizing. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358 (2003), 459–473, 10.1098/rstb.2002.1218.
108. Frith, C.D., Frith, U., The neural basis of mentalizing. Neuron 50 (2006), 531–534, 10.1016/j.neuron.2006.05.001.
109. Fusar-Poli, P., Allen, P., Lee, F., Surguladze, S., Tunstall, N., Fu, C.H.Y., Brammer, M.J., Cleare, A.J., McGuire, P.K., Modulation of neural response to happy and sad faces by acute tryptophan depletion. Psychopharmacology (Berl.) 193 (2007), 31–44, 10.1007/s00213-007-0757-4.
110. Gallagher, H.L., Frith, C.D., Functional imaging of theory of mind. Trends Cogn. Sci. 7 (2003), 77–83.
111. Ghashghaei, H.T., Barbas, H., Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience 115 (2002), 1261–1279.
112. Giusti-Rodríguez, P., Sullivan, P.F., The genomics of schizophrenia: update and implications. J. Clin. Investig. 123 (2013), 4557–4563, 10.1172/JCI66031.
113. Gobbi, G., Murphy, D.L., Lesch, K., Blier, P., Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 296 (2001), 987–995.
114. Gottesman, I., Gould, T.D., The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 (2003), 636–645.
115. Grady, C.L., Siebner, H.R., Hornboll, B., Macoveanu, J., Paulson, O.B., Knudsen, G.M., Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks. Eur. Neuropsychopharmacol. 23 (2013), 368–378, 10.1016/j.euroneuro.2012.06.003.
116. Gusnard, D.A., Akbudak, E., Shulman, G.L., Raichle, M.E., Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 4259–4264, 10.1073/pnas.071043098.
117. Hajós, M., Richards, C.D., Székely, A.D., Sharp, T., An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87 (1998), 95–108.
118. Hajós, M., Hajós-Korcsok, E., Sharp, T., Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 126 (1999), 1741–1750, 10.1038/sj.bjp.0702510.
119. Hardee, J.E., Thompson, J.C., Puce, A., The left amygdala knows fear: laterality in the amygdala response to fearful eyes. Soc. Cogn. Affect. Neurosci. 3 (2008), 47–54, 10.1093/scan/nsn001.
120. Hariri, A.R., Holmes, A., Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10 (2006), 182–191, 10.1016/j.tics.2006.02.011.
121. Hariri, A.R., Bookheimer, S.Y., Mazziotta, J.C., Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 11 (2000), 43–48, 10.1097/00001756-200001170-00009.
122. Hariri, A.R., Mattay, V.S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M.F., Weinberger, D.R., Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002), 400–403, 10.1126/science.1071829.
123. Hariri, A.R., Drabant, E.M., Munoz, K.E., Kolachana, B.S., Mattay, V.S., Egan, M.F., Weinberger, D.R., A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 62 (2005), 146–152, 10.1001/archpsyc.62.2.146.
124. Hariri, A.R., Drabant, E.M., Weinberger, D.R., Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol. Psychiatry 59 (2006), 888–897, 10.1016/j.biopsych.2005.11.005.
125. Harmer, C.J., Mackay, C.E., Reid, C.B., Cowen, P.J., Goodwin, G.M., Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol. Psychiatry 59 (2006), 816–820, 10.1016/j.biopsych.2005.10.015.
126. Harmer, C.J., Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 55 (2008), 1023–1028, 10.1016/j.neuropharm.2008.06.036.
127. Harrison, P.J., Weinberger, D.R., Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005), 40–68, 10.1038/sj.mp.4001558.
128. Haxby, J.V., Ungerleider, L.G., Clark, V.P., Schouten, J.L., Hoffman, E.A., Martin, A., The effect of face inversion on activity in human neural systems for face and object perception. Neuron 22 (1999), 189–199.
129. Haxby, J.V., Hoffman, E.A., Gobbini, M.I., The distributed human neural system for face perception. Trends Cogn. Sci. 4 (2000), 223–233.
130. Hay-Schmidt, A., The evolution of the serotonergic nervous system. Proc. Biol. Sci. 267 (2000), 1071–1079, 10.1098/rspb.2000.1111.
131. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., Lesch, K.P., Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 (1996), 2621–2624.
132. Heinz, A., Smolka, M.N., The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci. 17 (2006), 359–367.
133. Heinz, A., Jones, D.W., Mazzanti, C., Goldman, D., Ragan, P., Hommer, D., Linnoila, M., Weinberger, D.R., A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol. Psychiatry 47 (2000), 643–649.
134. Heinz, A., Braus, D.F., Smolka, M.N., Wrase, J., Puls, I., Hermann, D., Klein, S., Grusser, S.M., Flor, H., Schumann, G., Mann, K., Buchel, C., Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8 (2005), 20–21, 10.1038/nn1366.
135. Hernández, F., Gómez de Barreda, E., Fuster-Matanzo, A., Lucas, J.J., Avila, J., GSK3: a possible link between beta amyloid peptide and tau protein. Exp. Neurol. 223 (2010), 322–325, 10.1016/j.expneurol.2009.09.011.
136. Hervás, I., Vilaró, M.T., Romero, L., Scorza, M.C., Mengod, G., Artigas, F., Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24 (2001), 11–20, 10.1016/S0893-133X(00)00175-5.
137. Hoertnagl, C.M., Hofer, A., Social cognition in serious mental illness. Curr. Opin. Psychiatry 27 (2014), 197–202, 10.1097/YCO.0000000000000055.
138. Holmes, A., Lit, Q., Murphy, D.L., Gold, E., Crawley, J.N., Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2 (2003), 365–380.
139. Honey, G., Bullmore, E., Human pharmacological MRI. Trends Pharmacol. Sci. 25 (2004), 366–374, 10.1016/j.tips.2004.05.009.
140. Hornboll, B., Macoveanu, J., Rowe, J., Elliott, R., Paulson, O.B., Siebner, H.R., Knudsen, G.M., Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala. J. Psychopharmacol. 27 (2013), 903–914, 10.1177/0269881113494106.
141. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P., International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46 (1994), 157–203.
142. Hoyer, D., Hannon, J.P., Martin, G.R., Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 (2002), 533–554.
143. Hu, X.-Z., Lipsky, R.H., Zhu, G., Akhtar, L.A., Taubman, J., Greenberg, B.D., Xu, K., Arnold, P.D., Richter, M.A., Kennedy, J.L., Murphy, D.L., Goldman, D., Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78 (2006), 815–826, 10.1086/503850.
144. Hyman, S.E., The genetics of mental illness: implications for practice. Bull. World Health Organ. 78 (2000), 455–463.
145. Iadecola, C., Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5 (2004), 347–360, 10.1038/nrn1387.
146. Iarocci, G., Yager, J., Elfers, T., What gene-environment interactions can tell us about social competence in typical and atypical populations. Brain Cogn. 65 (2007), 112–127, 10.1016/j.bandc.2007.01.008.
147. Iidaka, T., Ozaki, N., Matsumoto, A., Nogawa, J., Kinoshita, Y., Suzuki, T., Iwata, N., Yamamoto, Y., Okada, T., Sadato, N., A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J. Neurosci. 25 (2005), 6460–6466, 10.1523/JNEUROSCI.5261-04.2005.
148. Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D.S., Quinn, K., Sanislow, C., Wang, P., Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167 (2010), 748–751, 10.1176/appi.ajp.2010.09091379.
149. Insel, T.R., The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am. J. Psychiatry 171 (2014), 395–397, 10.1176/appi.ajp.2014.14020138.
150. Invernizzi, R., Belli, S., Samanin, R., Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584 (1992), 322–324.
151. Jacobs, B.L., Azmitia, E.C., Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992), 165–229.
152. Jakab, R.L., Goldman-Rakic, P.S., 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 735–740.
153. Jankowski, M.P., Sesack, S.R., Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J. Comp. Neurol. 468 (2004), 518–529, 10.1002/cne.10976.
154. Jonassen, R., Foss Haug, K.B., Endestad, T., Bentsen, H., Grimholt, R.M., Landrø, N.I., Associations between serotonin transporter polymorphisms and cognitive processing applying the Emo 1-back task. Cogn. Emot. 27 (2013), 465–473, 10.1080/02699931.2012.726213.
155. Kandel, E.R., Squire, L.R., Neuroscience: breaking down scientific barriers to the study of brain and mind. Science 290 (2000), 1113–1120.
156. Kandel, E.R., A new intellectual framework for psychiatry. Am. J. Psychiatry 155 (1998), 457–469.
157. Karg, K., Burmeister, M., Shedden, K., Sen, S., The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68 (2011), 444–454, 10.1001/archgenpsychiatry.2010.189.
158. Karlović, D., Karlović, D., Serotonin transporter gene (5-HTTLPR) polymorphism and efficacy of selective serotonin reuptake inhibitors—do we have sufficient evidence for clinical practice. Acta Clin. Croat. 52 (2013), 353–362.
159. Karlsgodt, K.H., Bachman, P., Winkler, A.M., Bearden, C.E., Glahn, D.C., Genetic influence on the working memory circuitry: behavior, structure, function and extensions to illness. Behav. Brain Res. 225 (2011), 610–622, 10.1016/j.bbr.2011.08.016.
160. Kendler, K.S., Neale, M.C., Endophenotype: a conceptual analysis. Mol. Psychiatry 15 (2010), 789–797, 10.1038/mp.2010.8.
161. Kilford, E.J., Dumontheil, I., Wood, N.W., Blakemore, S.-J., Influence of COMT genotype and affective distractors on the processing of self-generated thought. Soc. Cogn. Affect. Neurosci., 2014, 10.1093/scan/nsu118.
162. Kilpatrick, L.A., Labus, J.S., Coveleskie, K., Hammer, C., Rappold, G., Tillisch, K., Bueller, J.A., Suyenobu, B., Jarcho, J.M., McRoberts, J.A., Niesler, B., Mayer, E.A., The HTR3A polymorphism c. −42C > T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology 140 (2011), 1943–1951, 10.1053/j.gastro.2011.03.011.
163. Kim, D.-K., Tolliver, T.J., Huang, S.-J., Martin, B.J., Andrews, A.M., Wichems, C., Holmes, A., Lesch, K.-P., Murphy, D.L., Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49 (2005), 798–810, 10.1016/j.neuropharm.2005.08.010.
164. Kiyasova, V., Gaspar, P., Development of raphe serotonin neurons from specification to guidance. Eur. J. Neurosci. 34 (2011), 1553–1562, 10.1111/j.1460-9568.2011.07910.x.
165. Klein, A.B., Santini, M.A., Aznar, S., Knudsen, G.M., Rios, M., Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice. Neuroscience 169 (2010), 1007–1016, 10.1016/j.neuroscience.2010.05.054.
166. Klomp, A., van Wingen, G.A., de Ruiter, M.B., Caan, M.W.A., Denys, D., Reneman, L., Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge. NeuroImage 75 (2013), 108–116, 10.1016/j.neuroimage.2013.03.002.
167. Klumpp, H., Fitzgerald, D.A., Cook, E., Shankman, S.A., Angstadt, M., Phan, K.L., Serotonin transporter gene alters insula activity to threat in social anxiety disorder. Neuroreport 25 (2014), 926–931, 10.1097/WNR.0000000000000210.
168. Kohler, C.G., Walker, J.B., Martin, E.A., Healey, K.M., Moberg, P.J., Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr. Bull. 36 (2010), 1009–1019, 10.1093/schbul/sbn192.
169. Kringelbach, M.L., Rolls, E.T., The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 72 (2004), 341–372, 10.1016/j.pneurobio.2004.03.006.
170. Kroes, M.C.W., van Wingen, G.A., Wittwer, J., Mohajeri, M.H., Kloek, J., Fernández, G., Food can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism. NeuroImage 84 (2014), 825–832, 10.1016/j.neuroimage.2013.09.041.
171. Lee, B.-T., Ham, B.-J., Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women. Genes Brain Behav. 7 (2008), 899–905, 10.1111/j.1601-183X.2008.00429.x.
172. Lee, K.H., Farrow, T.F.D., Spence, S.A., Woodruff, P.W.R., Social cognition, brain networks and schizophrenia. Psychol. Med. 34 (2004), 391–400.
173. Lee, M., Bailer, U.F., Frank, G.K., Henry, S.E., Meltzer, C.C., Price, J.C., Mathis, C.A., Putnam, K.T., Ferrell, R.E., Hariri, A.R., Kaye, W.H., Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. Mol. Psychiatry 10 (2005), 715–716, 10.1038/sj.mp.4001680.
174. Leppänen, J.M., Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings. Curr. Opin. Psychiatry 19 (2006), 34–39, 10.1097/01.yco.0000191500.46411.00.
175. Lerer, B., Macciardi, F., Segman, R.H., Adolfsson, R., Blackwood, D., Blairy, S., Del Favero, J., Dikeos, D.G., Kaneva, R., Lilli, R., Massat, I., Milanova, V., Muir, W., Noethen, M., Oruc, L., Petrova, T., Papadimitriou, G.N., Rietschel, M., Serretti, A., Souery, D., Van Gestel, S., Van Broeckhoven, C., Mendlewicz, J., Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiatry 6 (2001), 579–585, 10.1038/sj.mp.4000883.
176. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H., Murphy, D.L., Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996), 1527–1531.
177. Leysen, J.E., 5-HT2 receptors. Curr. Drug Targets CNS Neurol. Disord. 3 (2004), 11–26.
178. Li, Q., Wichems, C.H., Ma, L., Van de Kar, L.D., Garcia, F., Murphy, D.L., Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J. Neurochem. 84 (2003), 1256–1265.
179. Lieben, C.K.J., Blokland, A., Westerink, B., Deutz, N.E.P., Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein-carbohydrate mixture in the adult rat. Neurochem. Int. 44 (2004), 9–16.
180. Logue, S.F., Gould, T.J., The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol. Biochem. Behav. 123 (2014), 45–54, 10.1016/j.pbb.2013.08.007.
181. Lonsdorf, T.B., Golkar, A., Lindstöm, K.M., Fransson, P., Schalling, M., Ohman, A., Ingvar, M., 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Biol. Psychol. 87 (2011), 106–112, 10.1016/j.biopsycho.2011.02.014.
182. Lu, B., Nagappan, G., Lu, Y., BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb. Exp. Pharmacol. 220 (2014), 223–250, 10.1007/978-3-642-45106-5_9.
183. Ma, Y., Li, B., Wang, C., Zhang, W., Rao, Y., Han, S., Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network. Br. J. Psychiatry, 2015, 10.1192/bjp.bp.114.150128.
184. Ma, Y., Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis. Mol. Psychiatry 20 (2015), 311–319, 10.1038/mp.2014.24.
185. Maren, S., Quirk, G.J., Neuronal signalling of fear memory. Nat. Rev. Neurosci. 5 (2004), 844–852, 10.1038/nrn1535.
186. Matthes, S., Mosienko, V., Bashammakh, S., Alenina, N., Bader, M., Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 85 (2010), 95–109, 10.1159/000279322.
187. Meek, S.E., Lemery-Chalfant, K., Jahromi, L.B., Valiente, C., A review of gene-environment correlations and their implications for autism: a conceptual model. Psychol. Rev. 120 (2013), 497–521, 10.1037/a0033139.
188. Meyer-Lindenberg, A., Weinberger, D.R., Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7 (2006), 818–827, 10.1038/nrn1993.
189. Meyer-Lindenberg, A., Hariri, A.R., Munoz, K.E., Mervis, C.B., Mattay, V.S., Morris, C.A., Berman, K.F., Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat. Neurosci. 8 (2005), 991–993, 10.1038/nn1494.
190. Meyer-Lindenberg, A., Buckholtz, J.W., Kolachana, B., Hariri, A.R., Pezawas, L., Blasi, G., Wabnitz, A., Honea, R., Verchinski, B., Callicott, J.H., Egan, M., Mattay, V., Weinberger, D.R., Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 6269–6274, 10.1073/pnas.0511311103.
191. Meyer-Lindenberg, A., The future of fMRI and genetics research. NeuroImage 62 (2012), 1286–1292, 10.1016/j.neuroimage.2011.10.063.
192. Mier, D., Kirsch, P., Meyer-Lindenberg, A., Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry 15 (2010), 918–927, 10.1038/mp.2009.36.
193. Mier, D., Lis, S., Neuthe, K., Sauer, C., Esslinger, C., Gallhofer, B., Kirsch, P., The involvement of emotion recognition in affective theory of mind. Psychophysiology 47 (2010), 1028–1039, 10.1111/j.1469-8986.2010.01031.x.
194. Mier, D., Sauer, C., Lis, S., Esslinger, C., Wilhelm, J., Gallhofer, B., Kirsch, P., Neuronal correlates of affective theory of mind in schizophrenia out-patients: evidence for a baseline deficit. Psychol. Med. 40 (2010), 1607–1617, 10.1017/S0033291709992133.
195. Miner, L.a.H., Backstrom, J.R., Sanders-Bush, E., Sesack, S.R., Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116 (2003), 107–117.
196. Moore, R.Y., Halaris, A.E., Jones, B.E., Serotonin neurons of the midbrain raphe: ascending projections. J. Comp. Neurol. 180 (1978), 417–438, 10.1002/cne.901800302.
197. Moreno, F.A., McGavin, C., Malan, T.P., Gelenberg, A.J., Heninger, G.R., Mathé, A.A., Delgado, P.L., Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling technique. Int. J. Neuropsychopharmacol. 3 (2000), 277–283, 10.1017/S1461145700002133.
198. Morris, J.S., Frith, C.D., Perrett, D.I., Rowland, D., Young, A.W., Calder, A.J., Dolan, R.J., A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383 (1996), 812–815, 10.1038/383812a0.
199. Morris, R.W., Weickert, C.S., Loughland, C.M., Emotional face processing in schizophrenia. Curr. Opin. Psychiatry 22 (2009), 140–146, 10.1097/YCO.0b013e328324f895.
200. Munafò, M.R., Clark, T.G., Roberts, K.H., Johnstone, E.C., Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression. Neuropsychobiology 53 (2006), 1–8, 10.1159/000089915.
201. Munafò, M.R., Brown, S.M., Hariri, A.R., Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry 63 (2008), 852–857, 10.1016/j.biopsych.2007.08.016.
202. Murphy, S.E., Norbury, R., O'sullivan, U., Cowen, P.J., Harmer, C.J., Effect of a single dose of citalopram on amygdala response to emotional faces. Br. J. Psychiatry 194 (2009), 535–540, 10.1192/bjp.bp.108.056093.
203. Murphy, S.E., Norbury, R., Godlewska, B.R., Cowen, P.J., Mannie, Z.M., Harmer, C.J., Munafò, M.R., The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis. Mol. Psychiatry 18 (2013), 512–520, 10.1038/mp.2012.19.
204. Nakamura, K., Hasegawa, H., Developmental role of tryptophan hydroxylase in the nervous system. Mol. Neurobiol. 35 (2007), 45–54.
205. Nakamura, M., Ueno, S., Sano, A., Tanabe, H., The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5 (2000), 32–38.
206. Nakamura, A., Maess, B., Knösche, T.R., Friederici, A.D., Different hemispheric roles in recognition of happy expressions. PLoS One, 9, 2014, e88628, 10.1371/journal.pone.0088628.
207. Naudts, K.H., Azevedo, R.T., David, A.S., van Heeringen, K., Gibbs, A.A., Epistasis between 5-HTTLPR and ADRA2B polymorphisms influences attentional bias for emotional information in healthy volunteers. Int. J. Neuropsychopharmacol. 15 (2012), 1027–1036, 10.1017/S1461145711001295.
208. Navailles, S., De Deurwaerdère, P., Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl.) 213 (2011), 213–242, 10.1007/s00213-010-2029-y.
209. Nishizawa, S., Benkelfat, C., Young, S.N., Leyton, M., Mzengeza, S., de Montigny, C., Blier, P., Diksic, M., Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 5308–5313.
210. Norbury, R., Taylor, M.J., Selvaraj, S., Murphy, S.E., Harmer, C.J., Cowen, P.J., Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl.) 206 (2009), 197–204, 10.1007/s00213-009-1597-1.
211. O'Nions, E.J.P., Dolan, R.J., Roiser, J.P., Serotonin transporter genotype modulates subgenual response to fearful faces using an incidental task. J. Cogn. Neurosci. 23 (2011), 3681–3693, 10.1162/jocn_a_00055.
212. Olivier, B., Serotonin: a never-ending story. Eur. J. Pharmacol. 753 (2015), 2–18, 10.1016/j.ejphar.2014.10.031.
213. Outhred, T., Das, P., Dobson-Stone, C., Griffiths, K., Felmingham, K.L., Bryant, R.A., Malhi, G., Kemp, A.H., The functional epistasis of 5-HTTLPR and BDNF Val66Met on emotion processing: a preliminary study. Brain Behav. 2 (2012), 778–788, 10.1002/brb3.99.
214. Pardridge, W.M., The role of blood-brain barrier transport of tryptophan and other neutral amino acids in the regulation of substrate-limited pathways of brain amino acid metabolism. J. Neural Transm., 1979, 43–54.
215. Passamonti, L., Crockett, M.J., Apergis-Schoute, A.M., Clark, L., Rowe, J.B., Calder, A.J., Robbins, T.W., Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression. Biol. Psychiatry 71 (2012), 36–43, 10.1016/j.biopsych.2011.07.033.
216. Paus, T., Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev. Neurosci. 2 (2001), 417–424, 10.1038/35077500.
217. Persico, A.M., Napolioni, V., Autism genetics. Behav. Brain Res. 251 (2013), 95–112, 10.1016/j.bbr.2013.06.012.
218. Pezawas, L., Meyer-Lindenberg, A., Drabant, E.M., Verchinski, B.A., Munoz, K.E., Kolachana, B.S., Egan, M.F., Mattay, V.S., Hariri, A.R., Weinberger, D.R., 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8 (2005), 828–834, 10.1038/nn1463.
219. Pezawas, L., Meyer-Lindenberg, A., Goldman, A.L., Verchinski, B.A., Chen, G., Kolachana, B.S., Egan, M.F., Mattay, V.S., Hariri, A.R., Weinberger, D.R., Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol. Psychiatry 13 (2008), 709–716, 10.1038/mp.2008.32.
220. Phillips, M.L., Young, A.W., Senior, C., Brammer, M., Andrew, C., Calder, A.J., Bullmore, E.T., Perrett, D.I., Rowland, D., Williams, S.C., Gray, J.A., David, A.S., A specific neural substrate for perceiving facial expressions of disgust. Nature 389 (1997), 495–498, 10.1038/39051.
221. Porcelli, S., Fabbri, C., Serretti, A., Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur. Neuropsychopharmacol. 22 (2012), 239–258, 10.1016/j.euroneuro.2011.10.003.
222. Price, L.H., Malison, R.T., McDougle, C.J., McCance-Katz, E.F., Owen, K.R., Heninger, G.R., Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology 17 (1997), 342–350, 10.1016/S0893-133X(97)00084-5.
223. Price, L.H., Malison, R.T., McDougle, C.J., Pelton, G.H., Heninger, G.R., The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biol. Psychiatry 43 (1998), 339–347.
224. Quirk, G.J., Garcia, R., González-Lima, F., Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiatry 60 (2006), 337–343, 10.1016/j.biopsych.2006.03.010.
225. Raghanti, M.A., Stimpson, C.D., Marcinkiewicz, J.L., Erwin, J.M., Hof, P.R., Sherwood, C.C., Differences in cortical serotonergic innervation among humans, chimpanzees, and macaque monkeys: a comparative study. Cereb. Cortex 18 (2008), 584–597, 10.1093/cercor/bhm089.
226. Ramamoorthy, S., Bauman, A.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., Ganapathy, V., Blakely, R.D., Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning expression, and chromosomal localization. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 2542–2546.
227. Rauch, S.L., Shin, L.M., Phelps, E.A., Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research—past, present, and future. Biol. Psychiatry 60 (2006), 376–382, 10.1016/j.biopsych.2006.06.004.
228. Reilly, J.G., McTavish, S.F., Young, A.H., Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J. Psychopharmacol. 11 (1997), 381–392.
229. Riad, M., Garcia, S., Watkins, K.C., Jodoin, N., Doucet, E., Langlois, X., el Mestikawy, S., Hamon, M., Descarries, L., Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417 (2000), 181–194.
230. Richtand, N.M., McNamara, R.K., Serotonin and dopamine interactions in psychosis prevention. Prog. Brain Res. 172 (2008), 141–153, 10.1016/S0079-6123(08)00907-2.
231. Risch, N., Herrell, R., Lehner, T., Liang, K.-Y., Eaves, L., Hoh, J., Griem, A., Kovacs, M., Ott, J., Merikangas, K.R., Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301 (2009), 2462–2471, 10.1001/jama.2009.878.
232. Roberts, C., Price, G.W., Middlemiss, D.N., Ligands for the investigation of 5-HT autoreceptor function. Brain Res. Bull. 56 (2001), 463–469.
233. Robinson, O.J., Overstreet, C., Allen, P.S., Letkiewicz, A., Vytal, K., Pine, D.S., Grillon, C., The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala aversive amplification circuit. NeuroImage 78 (2013), 217–223, 10.1016/j.neuroimage.2013.03.075.
234. Rolls, E.T., Grabenhorst, F., The orbitofrontal cortex and beyond: from affect to decision-making. Prog. Neurobiol. 86 (2008), 216–244, 10.1016/j.pneurobio.2008.09.001.
235. Romero, L., Bel, N., Artigas, F., de Montigny, C., Blier, P., Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15 (1996), 349–360, 10.1016/0893-133X(95)00240-E.
236. Rule, R.R., Shimamura, A.P., Knight, R.T., Orbitofrontal cortex and dynamic filtering of emotional stimuli. Cogn. Affect. Behav. Neurosci. 2 (2002), 264–270.
237. Santana, N., Bortolozzi, A., Serrats, J., Mengod, G., Artigas, F., Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 14 (2004), 1100–1109, 10.1093/cercor/bhh070.
238. Sauer, C., Montag, C., Wörner, C., Kirsch, P., Reuter, M., Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: possible links to autism. Neuropsychopharmacology 37 (2012), 1474–1482, 10.1038/npp.2011.333.
239. Savitz, J., Lucki, I., Drevets, W.C., 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol. 88 (2009), 17–31, 10.1016/j.pneurobio.2009.01.009.
240. Scharinger, C., Rabl, U., Sitte, H.H., Pezawas, L., Imaging genetics of mood disorders. NeuroImage 53 (2010), 810–821, 10.1016/j.neuroimage.2010.02.019.
241. Schinka, J.A., Busch, R.M., Robichaux-Keene, N., A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 9 (2004), 197–202, 10.1038/sj.mp.4001405.
242. Seifuddin, F., Pirooznia, M., Judy, J.T., Goes, F.S., Potash, J.B., Zandi, P.P., Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry, 13, 2013, 213, 10.1186/1471-244X-13-213.
243. Serretti, A., Kato, M., De Ronchi, D., Kinoshita, T., Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry 12 (2007), 247–257, 10.1038/sj.mp.4001926.
244. Shimamura, A.P., The role of the prefrontal cortex in dynamic filtering. Psychobiology 28 (2000), 207–218.
245. Skuse, D.H., Gallagher, L., Genetic influences on social cognition. Pediatr. Res. 69 (2011), 85R–91R, 10.1203/PDR.0b013e318212f562.
246. Smits, K.M., Smits, L.J.M., Schouten, J.S.a.G, Stelma, F.F., Nelemans, P., Prins, M.H., Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol. Psychiatry 9 (2004), 433–441, 10.1038/sj.mp.4001488.
247. Sotelo, C., Cholley, B., El Mestikawy, S., Gozlan, H., Hamon, M., Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci., 2, 1990, 11441154.
248. Stefanacci, L., Amaral, D.G., Some observations on cortical inputs to the macaque monkey amygdala: an anterograde tracing study. J. Comp. Neurol. 451 (2002), 301–323, 10.1002/cne.10339.
249. Stein, C., Davidowa, H., Albrecht, D., 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse 38 (2000), 328–337, 10.1002/1098-2396(20001201)38:3<328:AID-SYN12>3.0.CO;2-T.
250. Stein, J., Wiedholz, L., Bassett, D., Weinberger, D., Zink, C., Mattay, V., Meyer-Lindenberg, A., A validated network of effective amygdala connectivity. Neuroimage 36 (2007), 736–745, 10.1016/j.neuroimage.2007.03.022.
251. Surguladze, S.A., Elkin, A., Ecker, C., Kalidindi, S., Corsico, A., Giampietro, V., Lawrence, N., Deeley, Q., Murphy, D.G.M., Kucharska-Pietura, K., Russell, T.A., McGuffin, P., Murray, R., Phillips, M.L., Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes Brain Behav., 7, 2008, 543551, 10.1111/j.1601-183X.2008.00390.x.
252. Surguladze, S.A., Radua, J., El-Hage, W., Gohier, B., Sato, J.R., Kronhaus, D.M., Proitsi, P., Powell, J., Phillips, M.L., Interaction of catechol O-methyltransferase and serotonin transporter genes modulates effective connectivity in a facial emotion-processing circuitry. Transl. Psychiatry, 2, 2012, e70, 10.1038/tp.2011.69.
253. Tan, H.-Y., Callicott, J.H., Weinberger, D.R., Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn. Neuropsychiatry 14 (2009), 277–298, 10.1080/13546800903091665.
254. Taylor, S.E., Way, B.M., Welch, W.T., Hilmert, C.J., Lehman, B.J., Eisenberger, N.I., Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol. Psychiatry 60 (2006), 671–676, 10.1016/j.biopsych.2006.04.019.
255. Terburg, D., Syal, S., Rosenberger, L.A., Heany, S., Phillips, N., Gericke, N., Stein, D.J., van Honk, J., Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology 38 (2013), 2708–2716, 10.1038/npp.2013.183.
256. Thoma, P., Friedmann, C., Suchan, B., Empathy and social problem solving in alcohol dependence, mood disorders and selected personality disorders. Neurosci. Biobehav. Rev. 37 (2013), 448–470, 10.1016/j.neubiorev.2013.01.024.
257. Thomason, M.E., Henry, M.L., Paul Hamilton, J., Joormann, J., Pine, D.S., Ernst, M., Goldman, D., Mogg, K., Bradley, B.P., Britton, J.C., Lindstrom, K.M., Monk, C.S., Sankin, L.S., Louro, H.M.C., Gotlib, I.H., Neural and behavioral responses to threatening emotion faces in children as a function of the short allele of the serotonin transporter gene. Biol. Psychol. 85 (2010), 38–44, 10.1016/j.biopsycho.2010.04.009.
258. Tost, H., Kolachana, B., Hakimi, S., Lemaitre, H., Verchinski, B.A., Mattay, V.S., Weinberger, D.R., Meyer-Lindenberg, A., A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 13936–13941, 10.1073/pnas.1003296107.
259. Uher, R., McGuffin, P., The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry 15 (2010), 18–22, 10.1038/mp.2009.123.
260. Van Donkelaar, E.L., Blokland, A., Ferrington, L., Kelly, P.a.T., Steinbusch, H.W.M., Prickaerts, J., Mechanism of acute tryptophan depletion: is it only serotonin?. Mol. Psychiatry 16 (2011), 695–713, 10.1038/mp.2011.9.
261. Van Marle, H.J.F., Tendolkar, I., Urner, M., Verkes, R.J., Fernández, G., van Wingen, G., Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals. NeuroImage 55 (2011), 825–831, 10.1016/j.neuroimage.2010.12.051.
262. Van der Does, A.J., The effects of tryptophan depletion on mood and psychiatric symptoms. J. Affect. Disord. 64 (2001), 107–119.
263. Van der Veen, F.M., Evers, E.A.T., Deutz, N.E.P., Schmitt, J.A.J., Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology 32 (2007), 216–224, 10.1038/sj.npp.1301212.
264. Verge, D., Daval, G., Patey, A., Gozlan, H., el Mestikawy, S., Hamon, M., Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur. J. Pharmacol. 113 (1985), 463–464.
265. Videtic, A., Peternelj, T.T., Zupanc, T., Balazic, J., Komel, R., Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav. 8 (2009), 541–545, 10.1111/j.1601-183X.2009.00505.x.
266. Vimaleswaran, K.S., Zhao, J.H., Wainwright, N.W., Surtees, P.G., Wareham, N.J., Loos, R.J.F., Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort. Int. J. Obes. 34 (2010), 1028–1033, 10.1038/ijo.2009.292.
267. Volman, I., Verhagen, L., den Ouden, H.E.M., Fernández, G., Rijpkema, M., Franke, B., Toni, I., Roelofs, K., Reduced serotonin transporter availability decreases prefrontal control of the amygdala. J. Neurosci. 33 (2013), 8974–8979, 10.1523/JNEUROSCI.5518-12.2013.
268. Von dem Hagen, E.A.H., Passamonti, L., Nutland, S., Sambrook, J., Calder, A.J., The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional faces. Neuropsychologia 49 (2011), 674–680, 10.1016/j.neuropsychologia.2010.12.013.
269. Walsh, N.D., Dalgleish, T., Dunn, V.J., Abbott, R., St Clair, M.C., Owens, M., Fairchild, G., Kerslake, W.S., Hiscox, L.V., Passamonti, L., Ewbank, M., Ban, M., Calder, A.J., Goodyer, I.M., 5-HTTLPR-environment interplay and its effects on neural reactivity in adolescents. NeuroImage 63 (2012), 1670–1680, 10.1016/j.neuroimage.2012.07.067.
270. Walters, J.T.R., Owen, M.J., Endophenotypes in psychiatric genetics. Mol. Psychiatry 12 (2007), 886–890, 10.1038/sj.mp.4002068.
271. Wang, L., Ashley-Koch, A., Steffens, D.C., Krishnan, K.R.R., Taylor, W.D., Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes Brain Behav. 11 (2012), 352–359, 10.1111/j.1601-183X.2012.00764.x.
272. Waring, J.D., Etkin, A., Hallmayer, J.F., O'Hara, R., Connectivity underlying emotion conflict regulation in older adults with 5-HTTLPR short allele: a preliminary investigation. Am. J. Geriatr. Psychiatry 22 (2014), 946–950, 10.1016/j.jagp.2013.08.004.
273. Wendland, J.R., Martin, B.J., Kruse, M.R., Lesch, K.-P., Murphy, D.L., Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 11 (2006), 224–226, 10.1038/sj.mp.4001789.
274. Wiggins, J.L., Bedoyan, J.K., Carrasco, M., Swartz, J.R., Martin, D.M., Monk, C.S., Age-related effect of serotonin transporter genotype on amygdala and prefrontal cortex function in adolescence. Hum. Brain Mapp. 35 (2014), 646–658, 10.1002/hbm.22208.
275. Williams, W.A., Shoaf, S.E., Hommer, D., Rawlings, R., Linnoila, M., Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J. Neurochem. 72 (1999), 1641–1647.
276. Williams, J.H.G., Perrett, D.I., Waiter, G.D., Pechey, S., Differential effects of tryptophan depletion on emotion processing according to face direction. Soc. Cogn. Affect. Neurosci. 2 (2007), 264–273, 10.1093/scan/nsm021.
277. Willins, D.L., Deutch, A.Y., Roth, B.L., Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27 (1997), 79–82, 10.1002/(SICI)1098-2396(199709)27:1<79:AID-SYN8>3.0.CO;2-A.
278. Windischberger, C., Lanzenberger, R., Holik, A., Spindelegger, C., Stein, P., Moser, U., Gerstl, F., Fink, M., Moser, E., Kasper, S., Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. NeuroImage 49 (2010), 1161–1170, 10.1016/j.neuroimage.2009.10.013.
279. Wise, R.G., Tracey, I., The role of fMRI in drug discovery. J. Magn. Reson. Imaging 23 (2006), 862–876, 10.1002/jmri.20584.
280. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 10th ed., 1992, World Health Organization, Geneva.
281. Wurtman, R.J., Hefti, F., Melamed, E., Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 32 (1980), 315–335.
282. Young, S.N., Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects. J. Psychiatry Neurosci. 38 (2013), 294–305, 10.1503/jpn.120209.
283. Yuen, E.Y., Jiang, Q., Chen, P., Feng, J., Yan, Z., Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J. Biol. Chem. 283 (2008), 17194–17204, 10.1074/jbc.M801713200.
284. Zammit, S., Owen, M.J., Stressful life events, 5-HTT genotype and risk of depression. Br. J. Psychiatry 188 (2006), 199–201, 10.1192/bjp.bp.105.020644.
285. Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., De Biasi, M., Dani, J.A., Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46 (2005), 65–74, 10.1016/j.neuron.2005.02.010.
286. Zhou, Z., Zhen, J., Karpowich, N.K., Law, C.J., Reith, M.E.A., Wang, D.-N., Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat. Struct. Mol. Biol. 16 (2009), 652–657, 10.1038/nsmb.1602.